Patent · US Active

Ready-to-use tranexamic acid intravenous solution

US10980757B2 · kind B2 · utility

1Cited by
15References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2019
Grant dateApr 20, 2021
Priority date
Expiry dateDec 2, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ready-to-use, stable aqueous intravenous tranexamic acid compositions are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.